Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a new revision label, updating from v3.5.3 to v3.5.4. This represents a small platform or page maintenance update without altering visible study content.SummaryDifference0.0%

- Check19 days agoChange DetectedEnrollment is updated to 700 participants. Primary completion is now 2027-12-01 and study completion is 2032-12-01, with related update dates 2026-04-30 and 2026-05-04.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe study details page has been updated to reflect a new set of participating sites, including additions of specific hospitals/centers and countries, and the total number of locations has increased (from 90 to 97). The record update date and the page revision/version have also been updated.SummaryDifference1%

- Check69 days agoChange DetectedRevision: v3.5.0 has been added, and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check105 days agoChange DetectedRevision history updated from v3.4.1 to v3.4.2. This is a metadata/version update and does not modify study details shown on the page.SummaryDifference0.0%

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.